TY - JOUR
T1 - Serotonin receptor expression in hippocampus and temporal cortex of temporal lobe epilepsy patients by postictal generalized electroencephalographic suppression duration
AU - Leitner, Dominique Frances
AU - Devore, Sasha
AU - Laze, Juliana
AU - Friedman, Daniel
AU - Mills, James D.
AU - Liu, Yan
AU - Janitz, Michael
AU - Anink, Jasper J
AU - Baayen, Johannes C.
AU - Idema, Sander
AU - van Vliet, Erwin Alexander
AU - Diehl, Beate
AU - Scott, Catherine
AU - Thijs, Roland
AU - Nei, Maromi
AU - Askenazi, Manor
AU - Sivathamboo, Shobi
AU - O'Brien, Terence
AU - Wisniewski, Thomas
AU - Thom, Maria
AU - Aronica, Eleonora
AU - Boldrini, Maura
AU - Devinsky, Orrin
N1 - Funding Information:
This research was supported by funding from the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) UO1 NS090415 05 Center for SUDEP Research: The Neuropathology of SUDEP, Finding a Cure for Epilepsy and Seizures, NIH National Institute of Aging (P30AG066512), European Union Seventh Framework Program (FP7/2007‐2013) under grant agreement 602102 (EPITARGET), Top Sector Life Sciences & Health via a PPP Allowance made available to the Dutch Epilepsy Foundation to stimulate public–private partnerships, and European Union Horizon 2020 WIDESPREAD‐05‐2020‐Twinning (EpiEpiNet, under grant agreement 952455).
Funding Information:
The authors declare no conflicts of interest. D.F. receives salary support for consulting and clinical trial‐related activities performed on behalf of the Epilepsy Study Consortium, a nonprofit organization. He receives no personal income for these activities. NYU receives a fixed amount from the Epilepsy Study Consortium toward D.F.'s salary. Within the past 2 years, the Epilepsy Study Consortium received payments for research services performed by D.F. from Alterity, Baergic, Biogen, BioXcell, Cerevel, Cerebral, Jannsen, Lundbeck, Neurocrine, SK Life Science, and Xenon. He has also served as a paid consultant for Neurelis Pharmaceuticals and Receptor Life Sciences. He has received travel support from the Epilepsy Foundation. He has received research support from the NINDS, Centers for Disease Control and Prevention, Epitel, and Neuropace unrelated to this study. He holds equity interests in Neuroview Technology. He has received royalty income from Oxford University Press. S.S. is supported by a Bridging Postdoctoral Fellowship from Monash University (BPF20‐3253672466) and the Victorian Medical Research Acceleration Fund. She reports salary support from Kaoskey and Optalert for clinical trial‐related activities; she receives no personal income for these activities. T.O. is supported by a program grant (APP1091593) and investigator grant (APP1176426) from the National Health and Medical Research Council of Australia and the Victorian Medical Research Acceleration Fund. He reports grants and consulting fees paid to his institution from Eisai, UCB Pharma, Praxis, Biogen, ES Theraputics, and Zynerba.
Publisher Copyright:
© 2022 International League Against Epilepsy.
PY - 2022/11
Y1 - 2022/11
N2 - Objective: Prolonged postictal generalized electroencephalographic suppression (PGES) is a potential biomarker for sudden unexpected death in epilepsy (SUDEP), which may be associated with dysfunctional autonomic responses and serotonin signaling. To better understand molecular mechanisms, PGES duration was correlated to 5HT1A and 5HT2A receptor protein expression and RNAseq from resected hippocampus and temporal cortex of temporal lobe epilepsy patients with seizures recorded in preoperative evaluation. Methods: Analyses included 36 cases (age = 14–64 years, age at epilepsy onset = 0–51 years, epilepsy duration = 2–53 years, PGES duration = 0–93 s), with 13 cases in all hippocampal analyses. 5HT1A and 5HT2A protein was evaluated by Western blot and histologically in hippocampus (n = 16) and temporal cortex (n = 9). We correlated PGES duration to our previous RNAseq dataset for serotonin receptor expression and signaling pathways, as well as weighted gene correlation network analysis (WGCNA) to identify correlated gene clusters. Results: In hippocampus, 5HT2A protein by Western blot positively correlated with PGES duration (p =.0024, R2 =.52), but 5HT1A did not (p =.87, R2 =.0020). In temporal cortex, 5HT1A and 5HT2A had lower expression and did not correlate with PGES duration. Histologically, PGES duration did not correlate with 5HT1A or 5HT2A expression in hippocampal CA4, dentate gyrus, or temporal cortex. RNAseq identified two serotonin receptors with expression that correlated with PGES duration in an exploratory analysis: HTR3B negatively correlated (p =.043, R2 =.26) and HTR4 positively correlated (p =.049, R2 =.25). WGCNA identified four modules correlated with PGES duration, including positive correlation with synaptic transcripts (p =.040, Pearson correlation r =.52), particularly potassium channels (KCNA4, KCNC4, KCNH1, KCNIP4, KCNJ3, KCNJ6, KCNK1). No modules were associated with serotonin receptor signaling. Significance: Higher hippocampal 5HT2A receptor protein and potassium channel transcripts may reflect underlying mechanisms contributing to or resulting from prolonged PGES. Future studies with larger cohorts should assess functional analyses and additional brain regions to elucidate mechanisms underlying PGES and SUDEP risk.
AB - Objective: Prolonged postictal generalized electroencephalographic suppression (PGES) is a potential biomarker for sudden unexpected death in epilepsy (SUDEP), which may be associated with dysfunctional autonomic responses and serotonin signaling. To better understand molecular mechanisms, PGES duration was correlated to 5HT1A and 5HT2A receptor protein expression and RNAseq from resected hippocampus and temporal cortex of temporal lobe epilepsy patients with seizures recorded in preoperative evaluation. Methods: Analyses included 36 cases (age = 14–64 years, age at epilepsy onset = 0–51 years, epilepsy duration = 2–53 years, PGES duration = 0–93 s), with 13 cases in all hippocampal analyses. 5HT1A and 5HT2A protein was evaluated by Western blot and histologically in hippocampus (n = 16) and temporal cortex (n = 9). We correlated PGES duration to our previous RNAseq dataset for serotonin receptor expression and signaling pathways, as well as weighted gene correlation network analysis (WGCNA) to identify correlated gene clusters. Results: In hippocampus, 5HT2A protein by Western blot positively correlated with PGES duration (p =.0024, R2 =.52), but 5HT1A did not (p =.87, R2 =.0020). In temporal cortex, 5HT1A and 5HT2A had lower expression and did not correlate with PGES duration. Histologically, PGES duration did not correlate with 5HT1A or 5HT2A expression in hippocampal CA4, dentate gyrus, or temporal cortex. RNAseq identified two serotonin receptors with expression that correlated with PGES duration in an exploratory analysis: HTR3B negatively correlated (p =.043, R2 =.26) and HTR4 positively correlated (p =.049, R2 =.25). WGCNA identified four modules correlated with PGES duration, including positive correlation with synaptic transcripts (p =.040, Pearson correlation r =.52), particularly potassium channels (KCNA4, KCNC4, KCNH1, KCNIP4, KCNJ3, KCNJ6, KCNK1). No modules were associated with serotonin receptor signaling. Significance: Higher hippocampal 5HT2A receptor protein and potassium channel transcripts may reflect underlying mechanisms contributing to or resulting from prolonged PGES. Future studies with larger cohorts should assess functional analyses and additional brain regions to elucidate mechanisms underlying PGES and SUDEP risk.
KW - hippocampus
KW - PGES
KW - serotonin
KW - SUDEP
UR - http://www.scopus.com/inward/record.url?scp=85137388158&partnerID=8YFLogxK
U2 - 10.1111/epi.17400
DO - 10.1111/epi.17400
M3 - Article
C2 - 36053862
AN - SCOPUS:85137388158
SN - 0013-9580
VL - 63
SP - 2925
EP - 2936
JO - Epilepsia
JF - Epilepsia
IS - 11
ER -